We have a rare opportunity for a new Race for Life sponsor 📢 Here's just a few of the fantastic benefits your company could receive: • Reach 250,000 participants in 160 cities 🏃♀️ • Connect with people at the heart of their community 👫 • Partner with the UK's most loved charity* ❤️ • Support life-saving cancer research 🔬 It only takes a minute to get in touch with our friendly partnerships team and kickstart the conversation 👉 https://cruk.ink/45PlVjX *Savanta BrandVue 2024 Report #RaceForLife #SponsorOpportunity #PartnerOpportunity
Cancer Research UK (CRUK)
Non-profit Organizations
We're the world’s largest charity dedicated to saving lives through research.
About us
Cancer Research UK is the world's leading cancer charity dedicated to saving lives through research, influence and information. Nearly one in two of us will get cancer in our lifetime, but we’re finding new ways to outsmart it, so that more people can live longer, better lives free from the fear of cancer. We carry out scientific research to help prevent, diagnose and treat cancer and our groundbreaking work, funded almost entirely by the general public, will ensure that millions more people survive. Together we are beating cancer. Registered charity No. 1089464.
- Website
-
http://www.cancerresearchuk.org
External link for Cancer Research UK (CRUK)
- Industry
- Non-profit Organizations
- Company size
- 1,001-5,000 employees
- Headquarters
- London
- Type
- Nonprofit
- Specialties
- cancer research, fundraising, volunteering, and charity events
Locations
-
Primary
2 Redman Place
London, E20 1JQ, GB
Employees at Cancer Research UK (CRUK)
Updates
-
Cancer Research UK (CRUK) reposted this
New research has revealed that symptom triggered testing can diagnose aggressive ovarian cancers before they spread 🩺 Since 2011, the NHS has offered this sort of rapid testing from women with frequent symptoms such as abdominal pain and bloating. Previously, some experts had thought this approach could only find cervical cancer in its more advanced stages, when it is harder for doctors to treat. However, the new study found that 1 in 4 women diagnosed through symptom triggered testing had early stage cancers, meaning surgeons could plan operations to completely remove them. Thanks to this research, led by a team at the University of Birmingham and supported by our funding, it's becoming clear that awareness of symptoms can help improve early detection and survival rates for ovarian cancer. Read more 👇 #OvarianCancer #CancerNews #CervicalCancer
-
New research has revealed that symptom triggered testing can diagnose aggressive ovarian cancers before they spread 🩺 Since 2011, the NHS has offered this sort of rapid testing from women with frequent symptoms such as abdominal pain and bloating. Previously, some experts had thought this approach could only find cervical cancer in its more advanced stages, when it is harder for doctors to treat. However, the new study found that 1 in 4 women diagnosed through symptom triggered testing had early stage cancers, meaning surgeons could plan operations to completely remove them. Thanks to this research, led by a team at the University of Birmingham and supported by our funding, it's becoming clear that awareness of symptoms can help improve early detection and survival rates for ovarian cancer. Read more 👇 #OvarianCancer #CancerNews #CervicalCancer
Symptom triggered testing helps doctors diagnose ovarian cancer early
Cancer Research UK (CRUK) on LinkedIn
-
We’re thrilled to share that Roadchef has raised an incredible £5.6 million for Cancer Research UK! 💙 From bake sales and marathons to roundups at the till, your support has been inspiring. Thanks to your efforts, we've made significant strides in our life-saving research. As this chapter draws to an end, we want to say a huge thank you for all we've achieved together. Thank you, Roadchef!👨🍳
-
Cancer Research UK (CRUK) reposted this
Delighted by the re-launch of our Tesco health charity partnership. Bringing together the expertise of Tesco, Cancer Research UK (CRUK), the British Heart Foundation and Diabetes UK to tackle the nation’s biggest health challenges. The partnership has achieved fantastic things since it first launched in 2018 and will continue to do so by empowering communities to lead healthier lives with more information and support about cancer, heart and circulatory disease and type-2 diabetes. Our partners play a key role in beating cancer and I'm delighted this health charity partnership will continue thanks to Tesco's ongoing support.
When it comes to leading healthier lives, we believe that every little help can make a big difference. That’s why we’re excited to continue our Health Charity Partnership with Diabetes UK, British Heart Foundation, and Cancer Research UK (CRUK). Here's a few things to look out for... 💙 You can now drop into your local pharmacy, where our colleagues have been given additional training from the charities to help customers lower their risk of conditions like cancer, type 2 diabetes and heart and circulatory disease. 🍲 Together, we’ve created new recipes to help manage and reduce the risk of heart disease and type 2 diabetes. Find out more here: https://lnkd.in/eAHWP6Hg
-
This morning on BBC Breakfast, the important work of Black in Cancer was highlighted, featuring insights from Sigourney Bonner, Magda Ali and Randy Greaves at the Cancer Research UK Cambridge Institute. Our Director of Evidence and Implementation Naser Turabi then joined presenters Ben and Sally on the breakfast sofa to shed light on the complexities of cancer inequalities and the dedicated efforts we are making to address them. Together, we are working to tackle health inequalities and improve outcomes for those from minority backgrounds, as well as emphasise the need for better representation in research 💪 #BlackinCancer #CancerResearch #DiversityInResearch
-
Cancer Research UK (CRUK) reposted this
I’m pleased to share my 6 monthly update on Cancer Research UK (CRUK)'s Equality, Diversity and Inclusion (EDI) strategy and plan. Like many of us, I am upset and angry about the unacceptable racist violence and riots that we’ve witnessed in recent weeks and welcome the opportunity to share what EDI means to our organisation. Beating cancer means beating it for everyone. Please take the time to read about our progress, challenges and how we’re building new ambitions for the future. Your feedback is welcome.
An update on equality, diversity and inclusion at Cancer Research UK
Michelle Mitchell OBE on LinkedIn
-
Relay For Life’s 10th Anniversary! 🪂 The Royal Naval Parachute Team landed at Tor Bridge High School in Plymouth, marking a memorable day dedicated to honouring those affected by cancer and raising vital funds for life-saving research. The day was filled with community spirit, featuring performances by Joanna Cooke, Donna Walker, and Tom Baker. Attendees also enjoyed an inflatable theme park and 5-a-side football matches. A special thank you to the Royal Navy and Devonport Naval Base Commander, Brigadier Mike Tanner OBE RM, for opening the event and inspiring us while sharing his cancer experience. Together, we’ve raised over £400,000 in the past decade 🙌 #RelayForLife #CommunityFundraising
-
How can colon capsule endoscopy (CCE) be used for bowel cancer investigation? 🧪 Researchers across the UK have initiated, in some cases completed, pilots to trial CCE as an initial investigation to free up endoscopy capacity and improve patient experience for people at risk of bowel cancer. The pill-sized camera works by travelling down the gastrointestinal tract and capturing images of the bowel, which are transmitted to a receiver and then analysed by a clinician. So far, only one CCE device is licensed for use in the UK, but uptake is gradually increasing due to its many advantages. Further research in this area should address current challenges so that more people can benefit from this type of test. Find out more in the comments 👇 #BowelCancer #Science #CancerResearch
-
Cancer vaccines: where are we now? 💉 Cancer vaccines are a kind of immunotherapy – which stimulates the immune system to attack cancer cells and shrink tumours. They’ve historically been difficult to pin down – every tumour is individual and it’s hard to get the immune system to target cancer cells without targeting healthy cells too. But we’re making progress all the time. Infinitopes (pictured) are just one team that’s harnessing the latest technology to produce the next generation of cancer vaccines. They’re using artificial intelligence (AI) to help identify individual protein signatures on tumour cells to help tell them apart from healthy cells. And it doesn’t stop there – research and clinical trials for cancer vaccines have soared over the last few years. We’ve already seen NHS England treat its first patient with a personalised cancer vaccine against their bowel cancer! With the strides being made, we could see an influx of cancer vaccines being offered as treatment options in the years to come. Check out our cancer vaccines immersive article here: https://cruk.ink/46I0tha